Grant: Strategic Projects - Group
Institut national de la recherche scientifique
$197,000.00
Electrochemical drug sensing with hydrophobic compound-adapted aptamers**
EF 2018-19
Résumé
Drug usage is responsible for numerous adverse effects on public health and safety (overdoses, car accidents, crime...). Accordingly, simple and rapid detection of illicit drug smuggling and of drug usage during driving is of paramount importance. The latter is particularly relevant in the context of the expected 2018 marijuana legalization, accompanied with a so-called ""zero-tolerance while driving"" policy for which appropriate detection-technology is not currently available. Detection often relies on non-optimal targets. For example, studies indicate that to evaluate driving impairment induced by cannabis, it would be more appropriate to use a ratio of THC (the main active ingredient of marijuana) and metabolized THC molecules. In parallel, volatile derivatives of cocaine are more useful for detection of drug smuggling.* Most of the current portable technologies use antibodies, which do not discern THC from its metabolites and do not bind to the most volatile compounds derived from drugs (like cocaine derivatives). The hydrophobicity of these drugs and their derivatives poses technical problems to find biosensing-molecules that recognize them. We plan to overcome this challenge with modified aptamers (which are DNA molecules that recognize target analytes with a tailored selectivity) combined to an electrochemical platform for transduction of the binding event. The proposed advances are expected to lead to biosensors for simple, cheap, ultrasensitive and rapid drug detection which will help counter drug smuggling and provide much needed tools for cannabis testing for drivers.* The partnership with the two companies involved and the team put together to achieve these goals combines high level expertise and infrastructures that will provide an outstanding environment for the training of students and PDFs. In addition, it will contribute to keep Canada at the forefront of aptamer and biosensing research as well as provide technologies to solve very current problematics in Canada.*
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
521437-2018
Name nom
Perreault, Jonathan
Department département
INRS-Institut Armand-Frappier, Centre
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
197000
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1586
Committee name en
Strategic Projects - Advanced Manufacturing
Committee name fr
Projets stratégiques - Fabrication de pointe
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Nucleic acids
Research subject fr
Acides nucléiques
Partie
1
Nb partie
1
Application title
Electrochemical drug sensing with hydrophobic compound-adapted aptamers**
Keyword
NSERC
Application summary
Drug usage is responsible for numerous adverse effects on public health and safety (overdoses, car accidents, crime...). Accordingly, simple and rapid detection of illicit drug smuggling and of drug usage during driving is of paramount importance. The latter is particularly relevant in the context of the expected 2018 marijuana legalization, accompanied with a so-called ""zero-tolerance while driving"" policy for which appropriate detection-technology is not currently available. Detection often relies on non-optimal targets. For example, studies indicate that to evaluate driving impairment induced by cannabis, it would be more appropriate to use a ratio of THC (the main active ingredient of marijuana) and metabolized THC molecules. In parallel, volatile derivatives of cocaine are more useful for detection of drug smuggling.* Most of the current portable technologies use antibodies, which do not discern THC from its metabolites and do not bind to the most volatile compounds derived from drugs (like cocaine derivatives). The hydrophobicity of these drugs and their derivatives poses technical problems to find biosensing-molecules that recognize them. We plan to overcome this challenge with modified aptamers (which are DNA molecules that recognize target analytes with a tailored selectivity) combined to an electrochemical platform for transduction of the binding event. The proposed advances are expected to lead to biosensors for simple, cheap, ultrasensitive and rapid drug detection which will help counter drug smuggling and provide much needed tools for cannabis testing for drivers.* The partnership with the two companies involved and the team put together to achieve these goals combines high level expertise and infrastructures that will provide an outstanding environment for the training of students and PDFs. In addition, it will contribute to keep Canada at the forefront of aptamer and biosensing research as well as provide technologies to solve very current problematics in Canada.*